These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8666365)

  • 1. Prognostic significance of biomarkers (c-erbB-2, p53, proliferating cell nuclear antigen, and DNA content) in salivary duct carcinoma.
    Felix A; El-Naggar AK; Press MF; Ordonez NG; Fonseca I; Tucker SL; Luna MA; Batsakis JG
    Hum Pathol; 1996 Jun; 27(6):561-6. PubMed ID: 8666365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphous low-grade adenocarcinoma: flow cytometric, p53, and PCNA analysis.
    Kelsch RD; Bhuiya T; Fuchs A; Gentile P; Kahn MA; Fantasia JE
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Oct; 84(4):391-9. PubMed ID: 9347503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salivary duct carcinoma: clinicopathological and immunohistochemical studies.
    Martinez-Barba E; Cortes-Guardiola JA; Minguela-Puras A; Torroba-Caron A; Mendez-Trujillo S; Bermejo-Lopez J
    J Craniomaxillofac Surg; 1997 Dec; 25(6):328-34. PubMed ID: 9504310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mucoepidermoid carcinoma of salivary glands: the prognostic value of tumoral markers].
    Hoyek-Gebeily J; Nehmé E; Aftimos G; Sader-Ghorra C; Sargi Z; Haddad A
    Rev Stomatol Chir Maxillofac; 2007 Dec; 108(6):482-8. PubMed ID: 17761202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic role of apoptotic, Bcl-2, c-erbB-2 and p53 tumor markers in salivary gland malignancies.
    Nagler RM; Kerner H; Ben-Eliezer S; Minkov I; Ben-Itzhak O
    Oncology; 2003; 64(4):389-98. PubMed ID: 12759537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of malignant grade of salivary gland tumors: studies by cytofluorometric nuclear DNA analysis, histochemistry for nucleolar organizer regions and immunohistochemistry for p53.
    Ishii K; Nakajima T
    Pathol Int; 1994 Apr; 44(4):287-96. PubMed ID: 8044296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and biomarker analyses of salivary duct carcinomas: comparison with mammary duct carcinoma.
    Hoang MP; Callender DL; Sola Gallego JJ; Huang Z; Sneige N; Luna MA; Batsakis JG; El-Naggar AK
    Int J Oncol; 2001 Oct; 19(4):865-71. PubMed ID: 11562768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Objective biologic parameters and their clinical relevance in assessing salivary gland neoplasms.
    Pinto AE; Fonseca I; Martins C; Soares J
    Adv Anat Pathol; 2000 Sep; 7(5):294-306. PubMed ID: 10976908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial-myoepithelial carcinoma of salivary glands. A clinicopathologic, DNA flow cytometric, and immunohistochemical study of Ki-67 and HER-2/neu oncogene.
    Cho KJ; el-Naggar AK; Ordonez NG; Luna MA; Austin J; Batsakis JG
    Am J Clin Pathol; 1995 Apr; 103(4):432-7. PubMed ID: 7726139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinicopathological study of salivary duct carcinoma].
    Shimizu A; Yamane M; Ito H; Araki S; Yoshida T; Suzuki M
    Nihon Jibiinkoka Gakkai Kaiho; 2002 Jun; 105(6):727-31. PubMed ID: 12138700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.
    Shiina H; Igawa M; Nagami H; Yagi H; Urakami S; Yoneda T; Shirakawa H; Ishibe T; Kawanishi M
    Cancer; 1996 Oct; 78(8):1762-74. PubMed ID: 8859190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoma ex pleomorphic adenoma: pathologic analysis of 73 cases.
    Lewis JE; Olsen KD; Sebo TJ
    Hum Pathol; 2001 Jun; 32(6):596-604. PubMed ID: 11431714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness.
    Sugano S; Mukai K; Tsuda H; Hirohashi S; Furuya S; Shimosato Y; Ebihara S; Takeyama I
    Laryngoscope; 1992 Aug; 102(8):923-7. PubMed ID: 1353853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive micropapillary salivary duct carcinoma: a distinct histologic variant with biologic significance.
    Nagao T; Gaffey TA; Visscher DW; Kay PA; Minato H; Serizawa H; Lewis JE
    Am J Surg Pathol; 2004 Mar; 28(3):319-26. PubMed ID: 15104294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The implications of TrkA and MET aberrations in de novo salivary duct carcinoma.
    Ryu HJ; Koh YW; Yoon SO
    Hum Pathol; 2018 Nov; 81():18-25. PubMed ID: 29753009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship between expressions of p53, c-erbB2 genes, proliferating cell nuclear antigen and prognosis of patients with ovarian epithelial carcinoma].
    Li JD; Li MD; Li YF; Huang X; Liu JH; Liu FY; Zhang CQ
    Ai Zheng; 2002 Mar; 21(3):292-6. PubMed ID: 12451998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acinic cell carcinoma of minor salivary glands: a clinical and immunohistochemical study.
    Triantafillidou K; Iordanidis F; Psomaderis K; Kalimeras E
    J Oral Maxillofac Surg; 2010 Oct; 68(10):2489-96. PubMed ID: 20678839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrosarcoma versus fibromatoses and cellular nodular fasciitis. A comparative study of their proliferative activity using proliferating cell nuclear antigen, DNA flow cytometry, and p53.
    Oshiro Y; Fukuda T; Tsuneyoshi M
    Am J Surg Pathol; 1994 Jul; 18(7):712-9. PubMed ID: 7517104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 overexpression in human esophageal carcinoma: a correlation with tumor DNA ploidy and two parameter flow cytometric study.
    Goukon Y; Sasano H; Nishihira T; Nagura H; Mori S
    Anticancer Res; 1994; 14(3B):1305-12. PubMed ID: 7915093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.
    Korkolopoulou P; Christodoulou P; Kapralos P; Exarchakos M; Bisbiroula A; Hadjiyannakis M; Georgountzos C; Thomas-Tsagli E
    Pathol Res Pract; 1997; 193(11-12):767-75. PubMed ID: 9521509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.